th century in Great Britain, Germany, and the USA, the most industrialized countries at that time. Milton C. Whitaker, in 1914, affirmed that the difference between Chemistry and Chemical Engineering lies in the capability of chemical engineers to transfer laboratory findings to the industrial level. Since then, Chemical Engineering underwent huge transformations determining the detachment from the original Chemistry nest. The beginning of the sixties of the 20 th century saw the development of a new branch of Chemical Engineering baptized Biomedical Engineering by Peppas and Langer and that now we can name Biological Engineering. Interestingly, although Biological Engineering focused on completely different topics from Chemical Engineering ones, it resorted to the same theoretical tools such as, for instance, mass, energy and momentum balances. Thus, the birth of Biological Engineering may be considered as a Darwinian evolution of Chemical Engineering similar to that experienced by mammals which, returning to water, used legs and arms to swim. From 1960 on, Biological Engineering underwent a considerable evolution as witnessed by the great variety of topics covered such as hemodialysis, release of synthetic drugs, artificial organs and, more recently, delivery of small interfering RNAs (siRNA). This review, based on the activities developed in the frame of our PRIN 2010-11 (20109PLMH2) project, tries to recount origins and evolution of Chemical Engineering illustrating several examples of recent and successful applications in the biological field. This, in turn, may stimulate the discussion about the Chemical Engineering students curriculum studiorum update.
INTRODUCTION

Birth of Chemical Engineering
The late nineteenth century saw a continuous growth of competition in the chemical industry among the leading countries at that time such as Great Britain, Germany and the USA [1] . Not surprisingly, in this context, Lewis M. Norton (Chemistry Department, MIT, Boston) established a course in Chemical Engineering. The topics of his course were mainly based on the activities developed in the German chemical industry, the world's most advanced at that historical moment. After of Norton's death (1893), Frank T. Horpe, who got a BS degree from MIT and a doctorate from the University of Heidelberg in 1893, succeeded him as field with the intention, however, of detaching from the tradition of Montecatini. The necessity, therefore, of quickly acquiring the appropriate scientific and technical background for the exploitation of the new chemical technologies, without resorting to a slow research process, required to approach the famous German chemical realities such as BASF and Bayer. The exigencies of a proper connection between the investor and the German technical counterpart, led, in 1958, to the foundation of AIDIC (Italian Association of Chemical Engineering). The establishment and the development of the famous Italian chemical industry parks of Marghera, Mantua and Priolo dates back to this period [4] . Obviously, the development of Chemical Engineering at academic level followed the industrial one and only in 1974 the Chemical Engineering researchers of University GRICU (Gruppo dei Ricercatori di Ingegneria Chimica dell'UNiversità) was founded. However, it should specified that, at that time, Chemical Engineering was already well included in the Italian university system and the formation of GRICU might be seen as a final acknowledgment of that new reality. Since then, the development has been rapid, varied [5] and rich in passionate discussions [6] about the best organization to be taken at national level.
Differentiation of Chemical Engineering
Although there was a clear evidence of widening of the Chemical Engineering cultural horizons towards traditionally far sectors such as Medicine, Biology, and Pharmacy only in the mid '70s, the birth of Biological Engineering (BE) is placed around the early '60s [1] . This evolution was due to talented American researchers (Elmer L. Gaden, Arthur B. Metzner, R. Byron Bird, Edward W. Merrill) who understood that chemical engineers could usefully contribute to areas other than the traditional ones. Accordingly, they underlined the importance of the inter-disciplinary approach which would have successively proved to be a winning strategy in modern research. Obviously, the realization of such a profound change was possible because major American organizations, such as the National Science Foundation and the National Institutes of Health, decided to invest in these new methodological approaches to Medicine, Biology and Pharmacy. As a result, between the early 60s and the late 70s, Merril (1959) investigated blood rheology, Leonard (1959) studied the artificial kidney, Colton (1966) focused on hemodialysis, Peppas worked on contact lenses (1976) and smart hydrogels (1979) while Langer (1979) delt with drug release from polymeric matrices. As it often happens, the first involvement of a chemical engineer in the biomedical field was completely fortuitous as a Boston physician requested Merrill's help in solving a problem concerning the measurement of blood viscosity. Consequently, relevant information regarding blood nonNewtonian characteristics related to strain rate intensity, hematocrit, and presence of various proteins and white blood cells were gathered. While Leonard [7] thoroughly investigated mass transport in hemodialysis devices, receiving from AIChE in 1969, a prestigious award for his fundamental contribution to designing and engineering artificial organs, Powers [8] , Lightfoot [9] and Dan Hershey [10] conducted important studies on mass transport in blood oxygenators. Colton [11] [12] [13] in mid '60s studied in detail the permeation of solutes through different membranes in order to select the best one to be employed in hemodialysis. At the same time, Lightfoot, by successfully analyzing the flow of Newtonian fluids through elastic pipes [14] , laid the foundation for the Ajit Yoganathan's work [15] on blood flow in artificial hearts. Due to the development of mathematical models and computing power, since the early '80s, Chemical Engineering could spread to areas of Medicine hitherto unattainable. In this regard, it is worth mentioning the study of the formation of atherosclerotic plaques based on mathematical models considering mass transport in the blood due to diffusion, convection, carriermediated and vesicular transport mechanisms [16] . All these scientific activities inevitably resulted in the publication of numerous papers and in the publication of several books, such as, for instance, Chemical Engineering in Medicine Undoubtedly, a very important contribution given by chemical engineers in Biomedicine concerned also biomaterials. According to Peppas and Langer [1] , this might be explained by the fact that chemical engineers had been pioneers in the study of polymeric materials. For instance, Colton studied cellulose acetate as hemodialyzer material (1966) , Hoffman and Merril explored hydrogels (1966) , Merril (1969) , Peppas (1975) and Sefton (1976) considered poly(vinyl alcohol), Cooper investigated polyurethanes (1972), Ratner focused on poly(hydroxyethyl methacrylate) (1973), Merril examined poly(ethylene oxide) (1974) and Langer analyzed polyanhydrides (1982) . In this context, it is important to remember the work of Hoffman on the use of polymerization by radiation to obtain biocompatible hydrogels. This activity inserted into a field, hydrogels, which, although already available since 1935, had become the subject of intense biomedical interest only after the pioneering work of Wichterle and Lim [17] who first prepared the famous polyhydroxyethylmethacrylate based gels, basic constituent material of soft contact lenses produced since the ʼ70s. In addition, Applied Thermodynamics and molecular theories gave a considerable contribution to designing and understanding the properties of various biomaterials, chiefly hydrogels. This led to the interesting studies on Polyvinyl alcohol-based gels designed for the release of heparin (blood anticoagulant) [18] , the production of high purity polymers for the formation of totally inert hydrogels to be used as cartilages and coatings of artificial hearts [19] .
Another topic covered by chemical engineers and very close to Biomedicine consisted in the designing of living tissues. The guiding principle of tissues engineering states that the formation of tissues or parts of human organs requires a proper spatial relationship of the cells. This may be realized by cells seeding in appropriate polymeric porous structure called scaffold, i.e. a support, or matrix, facilitating the migration, binding or transport of cells or bioactive molecules used to replace, repair or regenerate tissues [20] . For example, it was possible to obtain human nerve tissues, cartilage, and hepatocytes [21] [22] [23] . Similarly, chemical engineers have also dealt with the encapsulation of cells within polymeric structures to obtain the so-called immuneisolation membranes which are permeable to small molecules such as glucose or other nutrients, but impermeable to large molecules such as immunoglobulins and also impermeable to the cells of the immune system. Chick and Solomon [24] , by working on dogs, demonstrated how this technology could defeat diabetes. Indeed, by using a copolymer constituted by acrylonitrile and vinyl chloride, they derived a hollow ultrafiltration membrane permeable to glucose (molecular weight 180) and insulin (molecular weight 6000), but impermeable to antibodies (molecular weight over 150000).
Although with a some delay with respect to the USA, also in Italy biological engineering spread. Indeed, since the early ʼ90s, sections devoted to biotechnologies and pharmaceuticals have appeared in the main Italian Chemical Engineering meetings (e.g. GRICU -AIDIC) [25] . Activities connected to BE were developed in different Italian Universities such as Bologna, Napoli, Roma, Torino and Trieste, just to cite some examples. Subsequently, the cooperation between Industry and University has started as it happened in the case of the Politecnico di Milano and EURAND.
Drug Delivery
Undoubtedly, one of the most important contributions given by Chemical Engineering to the bio-medical field was that of drug delivery. Indeed, in the far 1976, Alan Michaels experimented how membranes can control the release of an active substance [26] . In addition, he also investigated the transdermal administration of active ingredients by developing a model to predict the permeation through the skin. Based on these studies, ALZA Corporation patented the transdermal administration of very important active drugs such as estradiol, scopolamine and nitroglycerin. If until the ʼ70s, releasing molecules with high molecular weight (> 300-400) from crosslinked polymers seemed unattainable, Langer and his group discredited this idea by studying the release of proteins and peptides. In particular, they found that when highly hydrophobic polymers, such as ethylene vinyl acetate or copolymers made by lactic and glycolic acids are mixed in proper conditions with macromolecules such as peptides or proteins, the highly porous structures obtained are able to release the macromolecules for months [27] . Based on these studies, several companies patented delivery systems dedicated to the release of peptides and proteins. It is worth recalling, for example, the luteinizing hormone release system such as Zoladex, Lupron Depot and Decapeptyl. While, in the early versions, release lasted a month, nowadays their duration reaches months. These systems are used for the treatment of prostate cancer, endometriosis and precocious puberty. More recently, delivery systems consisting of injectable microspheres releasing the human growth hormone guarantee release for 2-4 weeks after injection. In addition, the problem of in stent re-stenosis, lead to another interesting application of drug release. Indeed, coronary stenosis, a common atherosclerosis complication (the formation of atheromatous plaques on the coronary wall), is treated with the Percutaneous Transluminal Coronary Angioplasty (PTCA), a procedure leading to the enlargement of the stenotic portion of the coronary by means of an expanding balloon. Nevertheless, the high incidence of re-stenosis (30-40%) following PTCA [28] , required to consider alternative approaches. The use of stents, rigid scaffolds roughly similar to the spring of a pen, placed in the coronary vessel stenotic portion, emerged as an interesting therapeutic strategy due to the substantial reduction of re-stenosis occurrence compared with the simple PTCA treatment [29, 30] . However, stents partially solved re-stenosis problem. Indeed, while preventing coronary wall early elastic recoil and late remodelling, two well-known events leading to restenosis, stents induce neointimal hyperplasia, another name for ISR, due to the hyperproliferation of Vascular Smooth Muscle Cells (VSMCs) [31, 32] . In this regard, the employment of drug eluting stents (DES), i.e stents covered by a polymeric coating releasing a anti-proliferative drug such as small interfering RNAs, substantially reduced the VSMCs iperproliferation and the consequent re-stenosis rate [33, 34] . Clearly, DES optimisation requires a deep understanding of the phenomena ruling drug release from the polymeric coating [35] .
Naturally, this kind of understanding is not limited to DES, but it is also fundamental to the other controlled release systems (CRS), whose aim is to ensure the desired release kinetics. According to the release behavior, CRS can be classified into passively preprogrammed, actively preprogrammed, and actively self-programmed systems [36] . In passively preprogrammed systems, release rate is predetermined and unresponsive to external biological stimuli, while, in the actively preprogrammed ones, an external source is able to control release rate, as in the case of insulin and urea delivery [36, 37] . Obviously, selfprogrammed delivery systems represent the new generation of CRS (regardless of administration route) as they will be able to autonomously regulate release kinetics in response to external stimuli such as the concentration of a fixed analyte [37] . While 25 years ago the majority of CRS fell into the first category, nowadays the importance of the last two categories is considerably increasing [37] . Since their great versatility (applications in the fields of Contraception, Ophthalmology, Thrombosis prevention, Dentistry, Oncology, Alcoholism and Detoxification treatments, Diabetology and Veterinary), at the present time, CRS are the basis for the modern concept of therapeutic treatment whose goal is to increase drug effectiveness and patient compliance. This is the reason why the fabrication of CRS requires enormous efforts for what concerns design process. In this regard, one of the most important theoretical tools is represented by mathematical modeling, very popular among chemical engineers all over the world.
Mathematical modelling
Surely, the utilization of mathematical models is very advantageous during the design phase of CRS, as they allow to simulate and/or optimize release kinetics before fabrication, and chemical engineers proved to be very skilled in this field [38, 39] . Indeed, mathematical modeling requires to understand nature and relative importance of all physical phenomena governing drug release kinetics. This means that mathematical model, defined as a "mathematical metaphor of some aspects of reality" [40] , may be seen as the theoretical legitimacy of the experimental findings as affirmed centuries ago by Leonardo da Vinci: 'niuna umana investigazione si puo` dimandare vera scienzia, s'essa non passa per le matematiche dimostrazioni' ('no human investigation can be defined as true science if it cannot be mathematically demonstrated') [41] . In addition, mathematical modeling is assuming an increasingly important role in the light of the recent concept of "personalized medicine" implying the treatment of each single patient as a unique subject and, thus, overcoming the traditional view of average patient [42] . However, this strategy, greatly beneficial for the patient, poses the not negligible problem of patient uniqueness that, in turn, requires the definition of a rational approach to be fitted to each patient. It is easy to understand that mathematical models can play a very important role in this rational approach.
A classical example about the application of mathematical models in the drug delivery field is represented by the investigation of controlled release from polymeric gels [43] . Although greatly differing for the physico-chemical nature of constituent polymers (polyelectrolyte, neutral, hydrophilic, lyophilic, amphiphilic) and the type of interaction (physical, chemical) existing among polymeric chains, gels share the same structuring principle. Indeed, they may be considered as coherent systems, which show mechanical characteristics intermediate between solids and liquids and consist of a continuous medium in which high molecular weight molecules are dispersed and spatially arranged to form a three-dimensional continuous network extending throughout the entire system. The presence of crosslinks among different polymeric chains prevents network destruction, with the result that the entire structure is only swollen and not dissolved by the liquid phase. Simplistically speaking, such a system is comparable to a sponge soaked in a liquid. However, this is a particular sponge since, if strong bonds (typically chemical crosslinks) among chains prevail, the structure of the polymeric network is constant over time and, on the contrary, if weak crosslinks (typically physical bonds) are prevalent, chains are loosely connected and the similarity is inappropriate for the real situation. If, over time, the spatial density of the crosslinks among different chains is constant (in static conditions), the spatial distribution of those connections may change due to the mobility of chains and chain segments. Correspondingly, if, over time, the density and the average size of lattice are constant, each mesh may vary. The three-dimensional lattice is statistical, not permanent, and, in particular conditions, system may experience erosion. Obviously, the representation could be complicated by the simultaneous presence of two different polymeric networks forming an interpenetrated one [44] . The detailed knowledge of the polymeric network architecture is of paramount importance since the average dimension and the size distribution of the mesh represent valuable information to develop a reliable mathematical model describing release kinetics. Indeed, very often, one of the most important factors affecting drug release is represented by the accessibility of network structure to drug. This is the reason why many chemical engineers dealt with the fascinating topic of gel characterization by means of very diverse techniques.
STATE OF THE ART
In the previous section, the discussion was devoted to illustrate the origin of Chemical Engineering and the subsequent birth of Biological Engineering (BE). Interestingly, due to its Chemical Engineering origin, BE differs from clinical engineering (CE) which originated from electronic engineering. In general, while, CE is concerned with the design and the optimization of diagnostic instrumentation, BE focuses on healing via the design and optimization of proper delivery systems. In addition, the necessity of testing the reliability of increasingly advanced release systems in conditions as close as possible to the in vivo ones also pressured chemical engineers to investigate how to control cell growth and differentiation in order to obtain normal and pathological tissues.
In the next sections, without pretension to be exhaustive, some examples, mainly connected to our project PRIN 2010-11 (20109PLMH2) will be provided, starting with the process of delivery systems fabrication and finishing with the evaluation of drug in vivo effects.
Process Intensification
Modern industrial pharmaceuticals production is developed following rules and pipelines carried out after the achievement of approvals from health Authorities that occurs after the conclusion of the main steps involved in drug discovery (in-vitro/in-vivo testing, definition of suitable administration systems). A fruitful role in the development process is undoubtedly played by engineering sciences which have skills and tools to realize the principle of the translational medicine "from the bench to the bedside" [45] . Chemical Engineering, in particular, plays a relevant role because pharmaceutical processes on industrial scale are conducted by the application of proper and subsequent unit operations. Furthermore, type, operative conditions and order of unit operations (heating, drying, separation, size reduction or enlargement and so on) derive from pillars of Chemical Engineering approach such as mass, energy and momentum balances. In the 21
st Century due to the need to answer to the challenges of sustainable development, embracing all the fields of industrial productions, a new paradigm of Chemical Engineering was introduced [46, 47] . This consists in adopting strategies based on the needs of industrial processes to satisfy both the increasing market requirements and the mandatory rules in sustainable productions such as energy and raw material savings, and respect of environmental constraints of industrial-scale processes. Process intensification (PI) is the denomination of this new engineering tool that aims to achieve process miniaturization, reduce the capital cost, improve safety and energy efficiency, and improve product quality. PI also includes simpler scale-up procedures, possibility to allow the replacement of batch processing by small continuous reactors, which frequently give more efficient overall operation [47, 48] . In short, keywords of PI are: smaller, cheaper, safer, slicker [46] . Figure 1 sketches the main benefits of process intensification are sketched. As an example, due to the peculiarities of pharmaceutical and fine chemical productions, PI in these fields can offer a substantial shortening of the time to market by developing a continuous laboratory-scale process, which could be used directly as the commercial-scale process. In this frame, manufacturing of drug delivery systems is experiencing new methods and apparatuses to innovate traditional pharmaceutical procedures and to combine bio-world requirements with industrial constraints.
In this section, the use of intensified methods of processing which involve ultrasonic (US) and radiation energy sources such as microwaves (MW) are shortly presented as examples of research studies finalized to overcome the classic approach of the pharmaceutical techniques with the new manufacturing strategy of Chemical Engineering. Both ultrasonic and radiation energy constitute tools for process intensification since they involve much less energy with respect to conventional techniques commonly adopted in atomization of liquid (i.e. to produce fine droplets of liquid) and heating purposes, respectively.
To achieve fine droplets (used to encapsulate active ingredients), traditional liquid break-up devices use only a small fraction of the provided energy (centrifugal, kinetic or pressure energy) to atomize liquid. Most of it is indeed transformed into the particles' kinetic energy, often encompassing expensive plant configurations in recovering stages. These drawbacks can be reduced by using ultrasonic atomizers which allow to achieve drops with final velocity up to 1−10% lower than in hydraulic or air-atomizing nozzles, thus reducing fluid compression costs upstream and drying chamber size downstream. Furthermore, ultrasonic atomizers present advantages of easy installation, low exercise costs due to the absence of moving components, such as rotors and gears and of typical disadvantages of pneumatic nozzles (clogging, broad droplets distribution). In biomaterials treatments ultrasonic atomizers are suitable because they are subjected to a low mechanical stress that avoids the deactivation of bioactive ingredients [49, 50] .
Use of microwave technology in heating operations, also in pharmaceutical manufacturing, is having a crescent interest as a powerful tool in the drying/stabilization processes. The mechanism of heat transfer due to the direct interaction between materials (through molecular interaction) and electromagnetic field, allows high heating rate. Furthermore, depending upon the dielectric properties of the matter (features which express the energy coupling of a material with electromagnetic microwave field) relevant benefits of microwave heating can be found in volumetric and selective heating, better moisture leveling in the drying operation, possible high power densities development in the processing area, compact equipment, fast on and off switching [50 -53] .
Examples of applications of ultrasonic atomization technique and heating treatments assisted by microwave in developing of drug delivery systems are presented in the following. Typical requirements for pharmaceutical products such as micro-scale, high encapsulation efficiency, gastroresistance, prolonged release have been satisfied by using US and MW tools. Several vitamins are used as model active ingredient. Due to their highly degradable features, they could mimic the behaviour of drugs based on nucleic acid.
By ultrasonic atomization, micro-particles, made of natural polymers such as alginate and chitosan, have been prepared with the aim to produce suitable delivery systems for vitamins differening in solubility and molar mass such as B12, ergocalciferol and alpha-tocopherol.
Particles with matrix-like structure and high vitamins encapsulation efficiency have been obtained by using both chitosan and alginate polymers [49] . Feed solutions of alginate and chitosan, loaded with B12 vitamin, were sprayed in suitable crosslinking solutions (CaCl2 solution and tripolyphosphate solution, respectively) where gelled micro-droplets are achieved (700 -600 µm) and from which they are separated and sent to drying treatment. By this protocol micro-particles have been produced and in vitro B12 fast kinetic release was observed.
Alginate shell-core micro-structures, realised by using an ultrasonic double channel atomizer, allowed to overcome rapid releases obtaining, furthermore, improved gastroresistant vitamin delivery systems. A dedicated single-pot apparatus was developed to carry out in one vessel all the process stages: feed solutions atomization, alginate crosslinking and microwave drying, optimizing both the procedure and the experimental set-up (semi-continuous process, compact apparatus). Micro-particles with 40 µm in size, with high load in alpha-tocopherol (11.5%) and encapsulation efficiency (about 100%) were produced. Moreover, a comparative study conducted using convective and microwave drying treatments to obtain dried solid micro-particles confirmed that microwave treatment is fast (less than 30 min against more than 3 hours for convective drying) and it showed that microwave irradiation induced a little delay in alpha-tocopherol release, an effect that is desirable for slow drug delivery kinetics [50] . The same protocol and apparatus were applied to produce alginate shell-core micro-structures encapsulating ergocalciferol (D2 vitamin). Due to the D2 features, pluronic F127 solution was added in core feed solution to obtain an appreciable yield of encapsulation limiting the loss of vitamin D2 in crosslinking solution. Moreover, different microwave drying conditions were explored [54] . Obtained micro-particles showed very fine micro-size, less than 10 µm, due to the added pluronic ingredient, with and high encapsulation efficiency (about 100%) if mild radiation condition was applied (pulsed irradiation at 230 W, treatment time 30 min against 12 hours for suitable convective drying). Additionally, enteric properties of produced micro-particles were assayed and confirmed by in vitro tests.
Furthermore, Shell−core structures based on alginate and Eudragit® copolymers were prepared using ultrasonic atomization and two-stage polyelectrolyte complexation [55] . In particular, water solutions of the anionic biopolymer alginate, containing the gastro-lesive drug indomethacin (core solution), were sprayed in fine droplets which were complexed with a cationic (meth)acrylate copolymer, Eudragit® E 100, and then with the anionic copolymer Eudragit® L30D-55. The first complexation stage was applied to achieve a high drug encapsulation efficiency, the second one to achieve gastro-resistance feature. Obtained optimized structures have shown micro-size, 140 µm, high load in indomethacin (2.75%) and encapsulation efficiency (74%).
Micro-containers
One of the biggest challenges in the pharmaceutical industry is the search of safe, less invasive and effective administration routes of active pharmaceutical ingredients (APIs). The oral route is still the most preferred, as it avoids pain, offers good patient compliance and usually requires no assistance. However, in the development of oral drug delivery systems, pharmaceutical research is finding severe obstacles, primarily due to the intrinsic physico-chemical nature of the new drug candidates, which in many cases exhibit low solubility, poor permeability and in general high vulnerability in the physiological environments. Indeed, between the oral ingestion and the final effect of the API, a sequence of barriers reduces its bioavailability: biological metabolism including enzymatic degradation, hydrolysis and chemical deactivation, slow dissolution compared to a relatively rapid peristaltic flow in the upper intestine, limited permeation through the mucosa [56] . In the field of gene and RNA interference therapies, an oral oligonucleotide delivery system must provide protection from the acidic gastric environments as well as from enzymatic attack from nucleases until the drug is absorbed [57] . An additional challenge to face in oral delivery lies in the low transfection efficiency of RNA and DNA therapeutics. This is attributed to the peculiarity of intestinal mucosal morphology and make-up preventing invasion of foreign particles via tight junctions besides the presence of a large number of degrading enzymes [58] . A direct consequence of these facts is that frequent administrations of drugs are needed in order to maintain an efficient therapeutic action with a consequent increasing occurrence of adverse effects.
Traditional oral dosage forms are produced by powder compaction and the most popular oral delivery systems are tablets. Tablets usually have large sizes, which often can be a problem for elder patients and kids. Moreover, the presence of different excipients often reduces significantly the drug loading in the single tablet.
One of the effects limiting the bioavailability of any drug, but particularly those with poor solubility, is the size and shape of the drug delivery system. Novel downscaling formulation strategies aim at encapsulating the API into micro-and nanoparticles [59, 60] where the drug release can be tuned according to the specific therapeutic needs and at the same time a more intimate contact with the irregular surface of the mucosa is provided. However, spherical micro-particles often suffer of large size distributions [61] , as well as poor chemical and physical stability [62] . Once arrived in the intestine, micro-particles float in the luminal fluid and start releasing the drug in any directions with a consequent loss of substance.
In recent years, Chemical Engineering and microfabrication contributed with innovative drug delivery systems at the micro-and nanoscales which aim to solve peculiar limitations of micro-and nanoparticles.
Recently, the interest in micro-fabricated drug delivery devices is increasing [63, 64] . This new concept of oral drug delivery device aims to address the following needs: (i) provide protection with a resistant shell to the API, (ii) deliver the API at a specific region in the Gastro Intestinal Tract (GIT) (preferably the small intestine), (iii) have small dimensions falling in the range of microns with a narrow size distribution, (iv) limit drug loss in the intestine by means of a combination of unidirectional release and adhesion to intestinal mucus, (v) preserve the stability of the formulation. Such a device was originally conceived as a micro-reservoir containing a drug formulation. Figure 2 provides a schematic representation of the micro-container concept and its features is provided. The micro-reservoir supplies an inert shell that protects the API from destabilizing and degrading agents. It has an opening on one side, from which the drug is released. In order to bestow such complex features to a single device, multiple steps are required. The common bottom up design itself, with tuning of accurate mixing and transformation of chemical compounds seems quite difficult to apply for this purpose. Fabrication methods with a top-down approach seem more appropriate. The following section summarizes the main contributions in the field of micro-fabricated devices for oral drug delivery. A device with the features above listed was originally conceived in a patent filed 07.01.2000 and later presented as research work [65] . The first micro-devices were realized as a proof of concept with porous silicon micro-particles loaded with protein-based therapeutics [66, 67] . Particular interest was arisen by reservoir-based micro-devices for water insoluble compounds and protein-based therapeutics. Tejal Desai and co-workers developed many prototypes of microfabricated devices for oral drug delivery, which represent the state of the art in this field. The first devices were manufactured in silicon with a bio-adhesive lectin-based coating [68] . The bio-adhesion of this prototype was tested on CaCo-2 cell monolayers [69] . Several more advanced prototypes were developed by using various materials: silicon [70] (Figure 3) , poly(methyl methacrylate) (PMMA) [71] , poly(lactic-co-glycolic acid) (PLGA) and gelatin [72] . a b This design allows the loading of different therapeutics (see Figure 4a and b) which can be delivered either sequentially, simultaneously, or independently and with tuneable release kinetics [75] . All these devices have in common a flat geometry, which was demonstrated to have a stronger adhesion to a cell monolayer as compared to spherical micro-particles [70] .
Derek Hansford co-workers. carried out remarkable research within the field of self-folding microcapsules for oral drug delivery [76] [77] [78] . Materials used in this case are PLGA, poly(ethylene glycol methacrylate) (PEGMA), and chitosan [76] . Typical sizes for the microstructures fall in the range of 45-90 µm wide containers containing reservoirs of 3-7 µm in depth. The volume available for drug loading is in the picoliter scale (2-7 pL). David H. Gracias and his co-workers developed different self-folding micro-carriers for drug delivery [79] [80] [81] . Figure  6 shows an SU-8 micro-cube with PCL hinges. The folding from 2D to a 3D arrangement is driven by surface tension: the microstructures are heated above the melting point of the hinge material and the faces close like shown in Figure 6b . Azam and co-workers [79] succeeded in encapsulating living biological components like bacteria and mammalian cells (see Figure 6a ). a Figure 6 . Cubic self-folding microcapsule in SU-8 and PCL filled with E. coli 24 h after staining (modified from [79] )
The fabrication of cylindrical micro-containers was introduced by Nagstrup et al. [82] . Thousands of containers with defined dimensions can be fabricated in the biodegradable polymers poly(L-lactic acid) (PLLA) and polycaprolactone (PCL) by means of hot embossing. Typically, the containers have an outer diameter of 300 µm and a cavity depth of 65 µm (see Figure 7) . More recently Petersen et al. presented a "hot punching" technique as a technical solution to remove the microdevices from the residual material after the hot embossing process [83, 84] .
New features have been implemented to micro-containers to improve the drug targeting to the upper intestine, where the permeability is higher. The application of an enteric polymer coating based on Eudragit L 100 on the open face of drug-filled micro-containers allows to protect the API from degradation in the gastric environment and to trigger the release in a specific region of the GIT according to the pH of the surrounding fluid [85] .
Furthermore, several oral drug formulations have been designed with the purpose of delivering therapeutics by using micro-containers as a carrier: amorphous furosemide salts [86] and insulin laden self emulsifying drug delivery systems (SNEDDS) [87] . However, the development of a feasible, robust and effective loading procedure for microcontainers has been proven a non-trivial task.
Marizza et al. recently developed inkjet printing for loading of drug solutions into micro-device reservoirs [88] . Each micro device is sequentially filled by an inkjet dispenses in a semi-automated manner with a predefined volume of liquid formulation. Micro-containers were filled with aqueous solutions of polyvinylpyrrolidone (PVP K10) showing the potential of precise and quasi-zero-waste performances. Marizza et al. subsequently combined this method with supercritical fluid impregnation [89] . The use of supercritical carbon dioxide as solvent for the hydrophobic drug allows loading large arrays of microcontainers in each experiment with a non-toxic and low cost solvent. In the attempt of enhancing the throughput of the loading technique Marizza and co-workers [90] recently replaced the injection of PVP with a simpler and more cost effective powder filling prior to the drug impregnation (see Figure 8) , thus increasing the throughput of the loading technique and without compromising the final accuracy of the loading. 
Modelling of drug delivery from hydrogels
Hydrogel-based drug delivery systems (HB-DSS), mainly in the form of tablets, are the most common pharmaceutical forms. They are able to give tailored drug release profiles, as function of kinds and concentrations of hydrogel-forming a polymer and drug. In principle, the HB-DSS can be used also for the controlled release of hard-to-deliver drugs, such as peptides and nucleic acid based drugs (including siRNAs). The drug release is a complex process, and its study requires knowledge and approaches typical of the methods of Chemical Engineering. The HB-DDs formulation requires to mix and compress a carrier (usually a cross-linked polymer able to form hydrogels), a drug, and various excipients [43] . When a dry swellable hydrogel-based tablet is immersed in a physiological fluid, the fluid starts penetrating inside the polymeric hydrophilic matrix. When a fixed threshold of solvent concentration is reached, the polymeric chains unfold due to a glass-rubber transition, and a gel-like layer is formed [43] . In the swollen region, the drug molecules can dissolve and can easily diffuse toward the outer dissolution medium. The polymer network becomes extremely hydrated where the swollen matrix is in contact with the outer medium (the so called "erosion front") and processes like chains disentanglement lead to matrix erosion [91] . It is, then clear, that a proper design of the delivery system requires knowing all the transport phenomena involved in the release process.
As this is not an easy task, these systems have been studied starting from a simplified system, the so called 'radial system' in which a tablet, made of pure HPMC, has been confined between two glass slabs to allow, during the dissolution, the transport phenomena to take place only by the lateral surface. The image of the hydrating cylinders was analysed to get a relationship between image colour intensities and water content in the gel [92] . However, this technique is affected by the environment lighting and the colour of the tablet. Thus, a more reliable technique was developed: the 'gravimetric technique'. It consists of the cutting of the swollen matrix in several annuli plus a central core. Each tablet section is weighted, dried and weighted again to determine the water content along the matrix radius. Eventually, the drug contained in each section is determined spectroscopically after the dissolution of the dried material. Using this technique the moving radius of the tablet (due to swelling and to erosion phenomena), the overall water uptake, drug and polymer masses evolution as well as the radial concentration of water, drug and polymer along the tablet radius [93] can be evaluated. The gravimetric technique allows improving the accuracy and reliability of the imageanalysis technique is also improved [94] . In addition, this technique was applied to more complex systems, where the water uptake occurs both radially and axially, in the so called 'semi-overall system'. In these systems, the tablet (half weighted respect to the previous one) is glued on a glass slab, which constitutes the symmetry plan of the whole system, and it undergoes dissolution. The left panel of Figure  9 shows a typical tablet shape after dissolution. Despite this technique allows obtaining a lot of information on the transport phenomena taking place during the dissolution, it is burdensome and time-consuming. A less laborious approach, with higher resolution, is based on the texture-analysis technique. An indentation test of radially hydrated tablets was designed and carried out by a textureanalyser (the radial system has been used to obtain samples whose water content was uniform along the tablet thickness direction). A relationship between work of penetration and water content of hydrogels was obtained [95] and a general relationship between water content and slope of forcedistance curve was found. The obtained relationship was successfully used to measure the water content in 'semioverall' samples, as a function of the hydration time, the radial direction, and the thickness direction [96] .
The application of modelling to hydrogel-based drug delivery systems is strictly related to the experimental work. A simple model based on a transient water mass balance in the system could be a 1D plus time problem with moving boundaries [92] . The code to solve the model can be a simple finite-difference scheme. The agreement between model predictions and experimental data on the pure-HPMC tablets investigated by the 'radial' method and by the image analysis technique was considered satisfying. Later, to simulate the behaviour of 3D systems in presence of axialsymmetry (as in case of the analysed tablets) with constant thickness/radius ratio, a literature approach [97] was coded and successfully applied to tablets shaped as cylinders [98] , also by comparison with the release data from a commercial tablet.
The main drawback of these models is the hypothesis of affine-deformation, i.e. the idea that the swelling/eroding cylinder changes its size keeping constant the shape and the thickness/radius ratio. Since the problem is an axialsymmetric one (2D plus time) with moving boundary and changing shape, the only way to overcome this inconvenience is to switch the mathematical approach to a FEM-based model (Finite Element Modelling), also accounting for the changing boundary. On these bases, a new model, able to capture all the observed behaviours, was proposed and validated [99] , and it was capable to describe the behaviour of the experimental data of both 'radial' and 'semi-overall' systems [99, 100] as well as of data from literature on a different drug [101] , and the drug release from porous micro-particles [102] . A further step toward a fully predictive model was achieved by removing the need for an optimization parameter to describe the swelling, thus perfecting the polymer mass balance at the swelling interface [103] .
At the end of this step, the full model [103] was also tested against data obtained by the 'texture analysis' technique, with very good results [104] , as shown in Figure  9 , right panel, where model predictions are compared with the experimental data of water content in a tablet after 6 hours of dissolution. Figure 9 reports also the balance equations with their initial and boundary conditions.
Materials characterization
A number of materials like colloids, granular materials, foams, gels, liquid crystals, and biological materials (examples of the so called soft materials), are becoming the main subject of study in different academic disciplines. The reasons dwell on their widespread use in industrial and biomedical applications, as well as on their intriguing properties far from traditional materials. Indeed, for example, gels resemble natural living tissue more than any other type of synthetic biomaterial [105] and they proved to be very promising for what concerns the release of proteins, peptides and other biological compounds such as siRNA [106] . Although these materials have different appearance and different mechanical and structural properties, they show several common features. First, the molecules self-organize on a mesoscopic scale (intermediate between micro and macro-scale) that controls the macroscopic behaviour of the material; in other words, they are mesoscopically heterogeneous. Second, their mobility is strongly reduced, like in crystalline solids, although, the phase appears disordered as that of liquids. In one word, they are a metastable system, and therefore they exhibit unusually slow relaxations and aging effects. Finally, many of the physical macroscopic properties scale with the temperature at which they operate. Therefore, they are sensitive to external conditions.
Compared to traditional materials, heterogeneous metastable systems pose several new challenges to their study. First, the dynamics of the sample is non-ergodic; namely, its correlation function, averaged over time, differs from the same quantity averaged over the space of all the system's states. Second, the dynamics may be timedependent; e.g., for systems undergoing aging effect the dynamics slow down with time.
To study this class of materials new techniques were developed recently. Particularly, scattering techniques were revisited to allow the direct measurement of the ensembleaveraged property usually detected by these techniques, i.e. the dynamic structural factor. The approach consists in averaging the dynamic structural factor not only over time, but also over a large number of different "volumes" in the Fourier space: the so-called speckles.
Speckle patterns (see Figure 10 ) occur when a monochromatic electromagnetic field, such as laser light or synchrotron x-ray, illuminates materials with a large number of scattering particles. At fixed angle, respect to the impinging field, each particle elastically scatters the photons at the same frequency, but with a different phase and amplitude. The result is a wave whose amplitude and intensity change randomly, i.e. the speckle pattern. When the speckles change in time, for instance, because of particles movement, the dynamic can be detected and directly correlated to the dynamics of the particles.
Based on the above idea, several dynamic and static scattering apparatuses were developed using different wavelength sources: Multispeckle Diffusing Wave Spectroscopy (DWS) (see Figure 10 ), Multispeckle Dynamic Light Scattering (DLS) and Multispeckle X-ray Photon Correlation Spectroscopy (XPCS). By way of example, Figure 10 reports the setup of the Multispeckle-DWS along with the interferometric pattern detected on a CCD camera.
Examples of application of these techniques include characterizations of both dynamic and static properties of soft materials. To give just few examples we report some of the articles on the field. In one of the earlier application of multispeckle technique, the speed of the local rearrangement following a mechanical perturbation in foams was investigated using multispeckle-DWS [107] . The study illustrated the interaction between the slow dynamics and aging, upon the application of a macroscopic deformation. In another earlier example [108] , instead, the behaviour of Laponite clay particle suspensions was investigated with the same technique. Here, for the first time, the decay time of the autocorrelation functions was found to increase linearly with sample's age. Multispeckle DLS, rather than DWS, was successfully applied to investigate the gelation of weakly attractive colloids [109] . The concentration and temperaturedependent kinetic arrest observed in the investigated micellar system was due to the existence of an attractive tail in the inter-particles potential [110] .
Combined techniques, like rheology and multispeckle light scattering, were often applied to those materials, displaying the same characteristic times and, thus, suggesting that the two techniques detect similar physical processes. On this respect, combined multispeckle DLS and linear rheology were applied on alginate gel [111] , thus allowing the detection of a hierarchical cross-link structure. Again, rheology, confocal microscopy, and multispeckle DLS, were also applied in a recent application on cytoskeletal network [112] . Here the authors clearly demonstrated that actin network accumulates stress during its formation.
In conclusion, the need to characterize materials with intrinsic structural complexity has guided the development of new investigation techniques. Among these, scattering techniques, already employed for the investigation of "traditional" materials, were modified in order to overcome some technical difficulties. The new techniques have led to an expansion of knowledge of such complex materials, although, further progress on this direction is still ongoing. For instance, the combined use of different techniques, like simultaneous dielectric and scattering techniques is also an intense area under development.
Human body as a Chemical plant
Current study of drug pharmacokinetics (PK) in mammals and more specifically in humans calls for a multi-, inter-, and trans-disciplinary approach (MITA). Pharmacokinetics entails the dynamic quantification of administered drugs in the different organs and tissues of patients. Specifically, drugs, once administered by means of different routes (e.g., oral, intravenous, aerial, dermal), are distributed, metabolized, and finally excreted (also known as ADME: Absorption, Distribution, Metabolism, Excretion) via complex pathways (also known as ADME pathways) that are mediated by the anatomical and physiological features of the mammalian body. The aforementioned MITA to PK requires the contribution from different perspectives and cultural backgrounds that are epitomized by physicians, pharmacists, biologists, chemists, and engineers [113] .
When engineers start approaching the PK subject, a good number of scientific papers and documents drive them through rather complex phenomena that, observed from a mechanistic perspective, require deepening the knowledge of both anatomy and physiology. Indeed, as soon as simplified one/two-compartment models are analysed [114] , an engineer can understand their limitations in terms of modelling details and physical consistency with the human body. However, there is also the opposite risk of introducing excessive detail in the PK model [115] , which can take to an over parametrized (i.e. 98 adaptive parameters) and overdimensioned model (i.e. 38 ordinary differential equations, ODE, for 21 compartments) whose usability is constrained to specific mammal species (i.e. rats) and limited to an administration route (i.e. intravenous administration). This is where physiologically based pharmacokinetic (PBPK) models come to hand, as they describe how the mammalian body undergoes the ADME pathways. As summarized by the acronym, this description is based on a phenomenological and mechanistic approach that lays its foundations on the coupled anatomical and physiological description of both organs and tissues that are interconnected by proper exchange routes, embodied by the circulatory and lymphatic systems. The engineer's perception of how organs and tissues work can be symbolized in terms of process units, unit operations, vessels, reactors, membranes, transport phenomena, ducts, inputs, outputs, recycles, and efficiencies. According to a process engineer's point of view, the mammalian body can be represented as a set of process units (i.e. compartments) that are interconnected, exchange material fluxes and symbolize either single or lumped organs/tissues [116, 117] . On one hand, some organs can be mathematically simulated by perfectly mixed tanks/reactors (such as stomach, liver, gallbladder, but also poorly perfused tissues, which on their turn lump different tissutal subsystems) as shown in Figure 11 . Figure 11 . According to an engineering process oriented approach to PK, some organs (e.g., the stomach) can be symbolized by a perfectly mixed tank reactor whose operation can be batch/semi batch.
On the other hand, some organs can be assimilated to plug flow ducts/reactors (see Figure 12 ) such as the small and large intestinal lumina where distributed mass fluxes cross the surrounding wall (i.e. the intestinal membrane) and transfer mass (i.e. nutrients and active principles) to the gastrointestinal circulatory system by means of two-way mass transfer coefficients. The mass transfer through the intestinal wall can be thought of a kind of diffusive phenomenon based on the Fick's law, although in reality the involved cellular membrane molecular exchange is active and more complicated than just a passive gradient-driven mass transfer (see Figure 13 ). Back to the plug flow representation of the intestinal lumina, this can be further simplified into a suitable series of perfectly-mixed tanks/reactors. By doing so, the partial differential equations, which describe the spatial-temporal mass fluxes, are discretized into a number of finite-difference equations and the translation into an ODE system makes the numerical solution easier and more efficient. At the same time, the organs/tissues represented in terms of compartments and symbolized as plant-equivalent equipment are interconnected by mass transfer routes. The process flow diagram, which graphically sketches the interconnected compartments, can comprise also recycles as discussed in Abbiati et al. [118, 119] where the enterohepatic circulation delineates the physical connection of gallbladder to duodenum through Oddi's sphincter. The periodic recycle of bile from the gallbladder to the intestinal lumen is mediated by Oddi's sphincter, which acts as a valve that switches from open to closed according to the feeding and digestive processes (see also Figure 14 ). Figure 14 . Schematization of the periodic enterohepatic circulation of bile mediated by the gallbladder that stores the bile produced by the hepatocytes in the liver and delivers it to the duodenum by means of the Oddi's sphincter that opens/closes subjected to the feeding/digestive processes. The most important bile substances (i.e., salts, nutrients, proteins, and active principles in case of medical treatment) are then partially reabsorbed from the intestinal lumen into the gastrointestinal circulatory system. The aforementioned body features bring to the simulation of periodic, batch, semi batch, and continuous processes as a function of the specific compartments. Every patient can be characterized by a personalized PBPK model depending on their sex, age, body mass index, and other related features. To account for these issues, the main organs such as the liver and the kidneys can be characterized by specific efficiencies as the ones that describe a catalyst, a heat exchanger, or a separation unit. The combination of all these elements allows writing a series of dynamic mass balances over the nodes of the body equipment (i.e. compartments), which take to an ODE system. There, the concentration variables for both organs and tissues are dependent variables that are numerically integrated to determine the PK profiles subjected to the ADME phenomena. Input and output streams to the mammalian body are represented respectively by administration routes and excretion pathways (see Figure  15 ). Once the organ/tissue concentrations are solved and diagrammed (Figure 16 ), they become a valuable decision support tool for the physicians who can better understand the distribution and metabolic pathways of drugs in the administered patients. These bits of information can support critical decisions on determining the total amount of active principle dispensed per body mass and time units to the patient and how to dynamically administer that amount to either shorten the relieve/heeling times or equalize the concentration distribution in case of chronic disease treatments [120] .
siRNA
siRNA are short double-stranded RNA molecules 22 nucleotides long that base their action on the ability to recognize, in a sequence-specific fashion, a target messenger RNA (mRNA). Upon binding, siRNAs trigger the destruction of the target mRNA and consequently of the protein encoded by the mRNA. By directing siRNAs against mRNAs encoding for proteins with pathological functions, it is possible to inhibit the deleterious effects of these proteins. As siRNAs can be engineered to hit virtually any target, they have a very broad applicability in several human diseases [121] [122] [123] [124] [125] .
Despite the great therapeutic potential, the practical use of siRNAs is very limited due to the lack of optimal delivery systems. When administered in vivo, siRNAs are exposed to blood and extracellular nucleases that induce their rapid degradation [126] . Additionally, naked siRNA barely pass through the cell membrane due to the electrostatic repulsion between the negatively charged phosphate groups present in the siRNA structure and the negatively charged surface of cellular membranes. Finally, the hydrophilic nature of siRNA does not allow the crossing of the hydrophobic layer of cellular membranes [127, 128] . Together, all the above considerations clearly indicate that if administered as naked molecules, an insignificant fraction of siRNA can reach the target cell/tissue resulting in negligible therapeutic effects.
Biological Engineering (BE) can substantially contribute to overcome the siRNA delivery problems by developing materials suitable to protect and target siRNAs to the diseased tissue/cells. Moreover, BE can also develop experimental systems suitable to test the effectiveness of siRNAs/delivery materials. In this regard, the effectiveness of siRNAs/delivery materials is typically first performed in simplified in vitro models and then in in vivo animal models. However, the use of animal models can be expensive and time consuming. In this case, BE can develop experimental systems more informative than in vitro models but less expensive and time consuming than in vivo models. For example, it is possible to develop a bioreactor containing a bio-scaffold having a pseudo-angiogenic system where tumour cells can be grafted. This model can reasonably mimic the in vivo tumour mass being easier to analyse, faster and cheaper than the employment of several animals. In addition, the substitution of animal models with a bioreactor allows accomplishing the rule of the three Rs (Replacement, Reduction Refinement) i.e the marked reduction of the number of animals necessary for the experiments.
Bioreactors can be, for example, used to test the targeting of bcl-2. This is an anti-apoptotic gene, which favours tumour cells survival; thus, its inhibition by siRNA should render the tumour cells more sensitive to apoptosis and thus prone to die. Another example is the siRNA-mediated targeting of the early growth response protein 1 (egr-1) [129] . This is a transcription factor able to mediate cell growth, proliferation, differentiation. Thus, its targeting by siRNAs can significantly reduce tumour cell growth and spreading. Accordingly, by using a bioreactor containing the appropriate tumour cells, it is possible to study the effectiveness of siRNA/delivery material distribution in the tissue as well as the biological effectiveness of the specific siRNA. Additionally, being a simplified system respect to the animal models, it may allow easily creating a mathematical model to interpret the biological phenomenon.
Cells motion
Cell motion plays a key role in a range of biological processes from development to wound healing. The classical Chemical Engineering foundations in transport phenomena and thermodynamics provide a sound framework for the quantitative study of cell motion. In broad terms and by using a terminology which has become popular in soft matter, cell motion can be classified as passive, when it is driven by convection of the suspending fluid, such as for blood cells, and active, when it is driven by the internal cell locomotion machinery, such as for fibroblast cells residing in connective tissues. Even in the apparently simpler passive case, cell motion is a complex biomechanical problem still to be fully elucidated. For example, cell transport in blood can be regarded as the flow of a concentrated suspension with non-Newtonian rheological behaviour in a complex vascular network. In the following, we review some basic issues on red blood cell (RBC) flow in microcirculation and on the description of active cell locomotion as a diffusive process.
Human blood is a non-Newtonian fluid constituted by a suspension of formed elements (i.e. red blood cells, white blood cells and platelets) in plasma, which can be seen as a Newtonian fluid under healthy physiological conditions. RBCs represent the big majority of formed elements (99%) and play the fundamental role of delivering oxygen to body tissues through the circulatory system [130, 131] . RBCs are elastic and deformable objects that are not provided with active movement, their transport and distribution in blood flow being only driven by the flow field in the vessels which, in turn, is dependent on pressure drops and on geometrical features of the vasculature (i.e. vessel diameter, bifurcations, changing of cross-section) [132 -134] . RBC high deformability enables changing their disk-like shape into a deformed one, which resembles a bullet or a parachute, allowing their pressure-driven flow through microcapillaries with inside diameter even smaller than cell size itself ( Figure  17 ). At any given pressure drop, RBC velocity stays in between the average and maximum velocity of the suspending fluid and increases with microcapillary diameter, likely due to the smaller disturbance of the flow field induced by RBCs of smaller size relative to the microcapillary diameter [135, 136] . Moreover, in such microconfined conditions (i.e. capillary diameter up to 10 m), RBCs tend to associate into clusters, small trains of cells separated from each other by a distance comparable to cell size (Figure 17 ). Experimental and numerical simulation showed that RBC flow-induced clustering is due to hydrodynamic interactions between consecutive cells and by the peculiar parachute shape assumed by RBCs during the flow in microcapillaries with dimension comparable to their size [136, 137] . In larger vessels, such as post-capillary venules and arterioles (i.e. diameter about 50-100 m), the velocity profile of RBCs is found to be lower than the velocity of the suspending fluid, whose velocity follows a parabolic trend, changing from zero at the vessel wall, due to the no-slip condition, to a maximum at the centre of the tube, resulting in a parabolic velocity profile [138] . This behaviour is well described by the Poiseuille law for steady flow in tubes under laminar flow conditions characterized by smooth streamlines and highly ordered motion, and is typical of the microcirculation, where the Reynolds number is well below the transition to turbulent flow. The reduction of RBC velocity in such conditions is due to the increment of suspension viscosity brought about by the presence of RBCs (volume fraction about 10-20% in physiological conditions). A similar velocity decrease was found for deformable objects, such as liquid vesicles and capsules, which are considered model systems of RBCs [139] . Regarding RBC radial distribution in microvessels, RBCs are pushed away from vessel wall by a wall-induced lift enhanced by their deformability. This effect is counterbalanced by the shear-induced diffusion that arises due to cell-cell collisions, leading to RBC migration towards the vessel centre-line, creating a RBC-rich core in the centre of the vessel and a cell-free layer (CFL) in proximity of the wall [140] . Figure 18 . RBC-rich core in the centre of the vessel and drug carrier margination in the cell-free layer in proximity of the wall.
Recently, it were reported that RBCs to affect the transport and distribution of micro carriers in drug delivery process in human microvasculature [138, 141] . In fact, while in the absence of RBCs, drug carrier velocity profile superimposes the parabolic Poiseuille profile, just following the motion of the fluid, a remarkable lowering of velocity profiles occurs in the presence of RBCs, due to the increment of suspension viscosity. Moreover, the flow of drug carriers in the RBC-rich core is affected by their collisions with RBCs, which cause carrier shear-induced slow diffusion in a size and shape dependent manner and, subsequently, a fast lateral displacement in the proximity of the CFL. The latter phenomenon is called "waterfall effect" and likely results from bypass regions through which particles can rapidly reach the CFL, which are related to the inhomogeneity of RBC spatial distribution [142] . The combination of the slow shear induced diffusion and the fast waterfall effect leads to the phenomenon of margination, the mechanism according to which particles migrate along vessel radius to the wall, which concentrate in the cell-free layer near the wall, due to their rigidity, allowing a rigidbody flipping motion near the wall1 [143, 144] , in analogy with the behaviour of platelets.
Cells can actively promote their motility, thanks to the interaction with the surrounding substrata. Directional movement of cells toward a concentration gradient, known as chemotaxis [145] , plays an important role in many pathological and physiological processes, such as wound healing, inflammation [146] , and tumour growth. Cancer invasion is related to the diffusional instability [147] mechanisms that can induce the separation of single or clustered cells from the main tumour body, which can then migrate toward the source of a nutrient, for example, a blood vessel, thus, invading wider areas and tissues. The evolution of cell systems in space and time can be described by considering a cell density function u(x,t). Cell density can be modelled in analogy with a reaction-diffusion system, as a function of two contributions, i.e., cell motility and proliferation, both involved in the spatial spreading of the cells. This approach, initially introduced to describe the propagation of an advantageous gene in a population [148] , was widely used to describe the advancement of cells invading fronts in the wound healing process [149 -151] . The Fisher-Kolmorgorov [148] model (eq.(1)) predicts cell density profiles u(x,t) to depend on cell motility and cell proliferation.
(1)
Cell proliferation is described as a logistic growth curve, and includes crowding effects by reducing the growth rate as the cell density approaches confluency k is the proliferation rate and is cell density at confluency [152] . Cell motility can be analysed according to the persistent random walk theory [153, 154] , where it is assumed that cell motion is characterized by a diffusion coefficient (also referred to as the random motility coefficient) D (μm 2 /min) and a persistence time P (min), the characteristic time during which cell movement persists in the same direction. The value of D is a quantitative measurement of cell migration and is related to both the average speed of cells and the persistence time. Cell motility is modelled in the FisherKolmorgorov equation as a Fickian, not Brownian, diffusion. Model extensions [155, 156] consider diffusivity as a decreasing function of cell density, to account for contact inhibition of cell movement, where collisions among the cells may lead to reorientation in cell paths and determine a change in cell movement direction, thus inhibiting cell migration. Experimental investigation of dynamic evolution of cell systems can be achieved by direct visualization techniques based on Time Lapse Microscopy [157] and image analysis, which enables to dynamically monitor specific regions of the sample, by iteratively acquiring images with a defined time frequency, while controlling the environmental parameters to ensure cell viability. A similar approach can be used also to investigate the interaction of non-biological soft matter, such as drugs, with biological tissues [158] .
FUTURE PERSPECTIVES
Obviously, it is always rather difficult, if not impossible, to predict the future developments of science since, as a matter of fact, science does not follow linear paths but it proceeds according to zig-zag trajectories required to overcome unexpected dead ends and unpredictable obstacles (many important discoveries occurred casually as it is well known). However, we firmly believe that, as witnessed by this paper, the multidisciplinary approach to science will play a fundamental role. In this regard, the recently emerging field of organs-on-chips offers endless possibilities for different biomedical applications, from Regenerative Medicine to drug screening and discovery. For instance, pharmaceutical companies and regulatory agencies are looking with strong interest towards organs-on-chip as new in vitro models and as high-content drug screening platform. The development of human organs-on-chip, where microscale engineering technologies are combined with cultured human cells to recapitulate the whole living organ microenvironment, also offers a unique opportunity to study human physiology and pathophysiology in an organ-specific context [159] [160] [161] . This technological perspective could provide an effective solution to the limitations of conventional cell culture systems that fail to recapitulate complex, organ-level disease processes in humans. In addition, it could overcome the use of costly and timeconsuming animal testing procedures, which often show poor predictive power of human biology and physiology. It is widely recognized that the paramount importance of developing new technologies, which allow to performing cost-effective and multi-parametric assays for ad hoc studies in development, disease and pathogenesis, or for screening specific therapeutic strategies.
The organ-on-chip concept takes advantages from the substantial technology miniaturization. In particular, the downscaling to microfluidic systems allows having an accurate control over the cellular microenvironment, which can be accurately controlled in space and time. The laminar flow regime allows fair description and prediction of mass flux inside and outside the cell culture, which define the biochemical properties for cellular soluble environments [162] . For instance, we showed that down scale of cell culture-volume within microfluidic platform could yield to substantial benefits in terms of cell behaviour and highthroughput [163, 164] . We also recently demonstrated that, in microfluidic conditions, the soluble cell-culture microenvironment is strongly perturbed by an incremental accumulation of exogenous and cell-secreted factors [165] .
In this context, recently, successful examples of organson-chip development were delivered for lung, liver or kidney [166] [167] [168] [169] . All these works provide clear evidences that the organ-on-chip technology could offer a wide range of applications to many biomedical applications. However, in all this work, all organs-on-chip were obtained from animal, and in few cases, from human primary cells. This could be a strong limitation for the clinical transferability of the data to the patients. The new frontiers in the field will be the integration of human cells within micro-technology context. In this direction, the development of organs-on-chip cultures starting from human pluripotent stem cells is still in its infancy. New understandings about organogenesis and embryo development are required to generate experimental conditions that preserve self-renewal or induce early differentiation and, later on, functional differentiation towards adult functional tissues or organs. On the other hand, human organ-on-chip allow studying cell-cell phenotype cross talk mediated through soluble environment in high-throughput fashion. These experimental studies are impossible to be performed with conventional cell culture systems. It is straightforward to developing a network of microfluidic cell-culture system in which a downstream cell culture is perturbed by an upstream cell culture.
In conclusion, this new and attractive field shows endless potential in mimicking human normal and pathological physiology of human organs or organ network while maintaining high measurement accessibility. Basic science and drug development will greatly benefit from functional organ-on-chips, both in terms of reliability of results and costs.
CONCLUSIONS
In the light of what shown in this paper, we believe that the growth and the development of BE, whose potentiality may be tremendous not only in the field of healthcare, will reflect in the necessity of new professional figures. Indeed, it is evident that really significant achievements in modern research imply a multidisciplinary approach. Accordingly, engineers, biologists, physicians, pharmacologists and chemists, for instance, might work side by side in daily research activity in order to share their own knowledge [170, 171] , thus overcoming the strong cultural barriers erected in the past in the name of knowledge categorization [43] . Thus, University, in its mission of educating future generations of researchers and managers, has to be ready to accomplish to this new demand as clearly pointed out at the beginning of the third millennium by authorities in this field [1, 172] . In the same period and on the same wavelength, prof. Annesini (Sapienza Università di Roma) felt the necessity of starting the discussion about the enlargement of the Chemical Engineering CV [173] . In particular, she said that, for example, courses dealing with biology, pharmacokinetics and genetics should be part of the CV of modern chemical engineers. Indeed, updating chemical engineers' curriculum studiorum will reflect not only in increasing job opportunities, but also in developing a better world where to live. Indeed, such rapid transformations taking place in our industrial society make mandatory for future managing class to culturally update in order to be able to feel and understand changes. Should this not the case, present and future generations will be unable to shape their future and become mere managers of emergencies, as stated, in the far 1975, by Piero Angela, a well-known Italian science writer [174] .
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